A study to evaluate whether Prasinezumab can slow or halt disease progression in people with a recent diagnosis of Parkinson’s disease.
A Study to Evaluate the Efficacy of RO7046015 in Participants With Early Parkinson’s Disease (PASADENA)
Neurodegenerative Disorder Parkinson's Disease (PD)
For the latest version of this information please go to www.forpatients.roche.com